Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.5 - $0.73 $20,530 - $29,973
-41,060 Reduced 73.4%
14,877 $7,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $26,849 - $39,155
55,937 New
55,937 $31,000
Q2 2023

Aug 14, 2023

SELL
$0.55 - $0.89 $72,989 - $118,110
-132,708 Reduced 74.29%
45,933 $34,000
Q1 2023

May 15, 2023

BUY
$0.68 - $1.25 $65,042 - $119,563
95,651 Added 115.26%
178,641 $126,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $56,822 - $79,314
59,190 Added 248.7%
82,990 $85,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $24,276 - $53,074
23,800 New
23,800 $31,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $31,646 - $65,312
-33,666 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $51,845 - $124,900
33,666 New
33,666 $66,000
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $81,755 - $123,900
-31,688 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $48,544 - $70,976
17,525 Added 123.74%
31,688 $107,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $24,218 - $58,634
14,163 New
14,163 $54,000
Q1 2021

May 17, 2021

SELL
$0.85 - $5.27 $14,104 - $87,450
-16,594 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$0.36 - $0.95 $5,973 - $15,764
16,594 New
16,594 $14,000
Q2 2020

Aug 14, 2020

SELL
$0.39 - $0.69 $4,936 - $8,734
-12,658 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.56 - $1.62 $7,088 - $20,505
12,658 New
12,658 $8,000
Q3 2018

Nov 14, 2018

SELL
$3.4 - $4.84 $35,948 - $51,173
-10,573 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.03 - $4.98 $32,036 - $52,653
10,573 New
10,573 $43,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $242M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.